Genetic analysis company Affymetrix Inc. has signed a definitive agreement to buy private eBioscience Inc. (oncology and immunology flow cytometry reagents) for $330mm in cash. (Nov.)
The acquisition gives Affymetrix a stronger presence in the molecular diagnostics market as the company slowly moves away from its...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?